Publications

  1. Burlile JF, Cameron JD, Gunn HJ, Larson NL, Bradt JL, Boughey JC, Mrdutt MM, Couch FJ, Olson JE, Cangie V, Ehlers S, Sharifzadeh Y, Ruddy KJ, Shumway DA, Loprinzi CL, Cathcart-Rake EJ. Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency. JCO Oncol Pract. 2025 Aug; 21 (8):1142-1152 Epub 2025 Jan 22
    View PubMed
  2. Burlile JF, Cameron JD, Gunn HJ, Larson NL, Bradt JL, Boughey JC, Mrdutt MM, Couch FJ, Olson JE, Cangie V, Ehlers S, Sharifzadeh Y, Ruddy KJ, Shumway DA, Loprinzi CL, Cathcart-Rake EJ. Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency. JCO Oncol Pract. 2025 Aug; 21 (8):1142-1152 Epub 2025 Jan 22
    View PubMed
  3. Conti RM, McCue S, Dockter T, Gunn H, Dusetzina S, Bennett A, Rapkin BD, Gracia G, Jazowski SA, Behrens R, Richardson PG, Chow S, Subbiah N, Neuman HB, Chang GJ, Weiss E. Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD). BMJ Open. 2025 Jun 3; 15 (6):e091769 Epub 2025 June 03
    View PubMed
  4. Conti RM, McCue S, Dockter T, Gunn H, Dusetzina S, Bennett A, Rapkin BD, Gracia G, Jazowski SA, Behrens R, Richardson PG, Chow S, Subbiah N, Neuman HB, Chang GJ, Weiss E. Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD). BMJ Open. 2025 Jun 3; 15 (6):e091769 Epub 2025 June 03
    View PubMed
  5. Ma J, Dragojevic S, Remmes NB, Mendelson NL, Kloeber JA, Ebner DK, Wu Z, Gunn HJ, Merrell KW, Hallemeier CL, Haddock MG, Jethwa KR, Lou Z, Mutter RW, Callaghan CM. Linear energy transfer optimized proton therapy for rectal cancer. Radiother Oncol. 2025 Jun; 207:110850 Epub 2025 Mar 16
    View PubMed
  6. Ma J, Dragojevic S, Remmes NB, Mendelson NL, Kloeber JA, Ebner DK, Wu Z, Gunn HJ, Merrell KW, Hallemeier CL, Haddock MG, Jethwa KR, Lou Z, Mutter RW, Callaghan CM. Linear energy transfer optimized proton therapy for rectal cancer. Radiother Oncol. 2025 Jun; 207:110850 Epub 2025 Mar 16
    View PubMed
  7. Andrews JR, Kim Y, Horjeti E, Arafa A, Gunn H, De Bruycker A, Phillips R, Song D, Childs DS, Sartor OA, Orme JJ, Chaudhuri AA, Tran P, Kiess A, Sutera P, Mercier C, Ost P, Park SS, Lucien F. PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts. Clin Cancer Res. 2025 Mar 17; 31 (6):1142-1149
    View PubMed
  8. Andrews JR, Kim Y, Horjeti E, Arafa A, Gunn H, De Bruycker A, Phillips R, Song D, Childs DS, Sartor OA, Orme JJ, Chaudhuri AA, Tran P, Kiess A, Sutera P, Mercier C, Ost P, Park SS, Lucien F. PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts. Clin Cancer Res. 2025 Mar 17; 31 (6):1142-1149
    View PubMed
  9. Snavely AC, Gunn HJ, Lee JW, Pugh SL, Barlow WE, Culakova E, Arnold KB, Kittel CA, Smith S, Hanlon BM, Tan AD, Dockter T, Zahrieh D, Dressler EV. Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP). J Natl Cancer Inst Monogr. 2025 Mar 1; 2025 (68):65-72
    View PubMed
  10. Dressler EV, Pugh SL, Gunn HJ, Unger JM, Zahrieh DM, Snavely AC. Practical design considerations for cluster randomized controlled trials: lessons learned in community oncology research. J Natl Cancer Inst Monogr. 2025 Mar 1; 2025 (68):56-64
    View PubMed
  11. Bandos H, Torres-Saavedra PA, Culakova E, Gunn HJ, Lee MK, Duan F, Cecchini RS, Unger JM, Dueck AC, Steingrimsson JA. Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials. J Natl Cancer Inst Monogr. 2025 Mar 1; 2025 (68):14-21
    View PubMed
  12. Enserro DM, Gunn HJ, Elsaid MI, Duan F, Pugh SL. Challenges to and considerations of designing cancer prevention trials. J Natl Cancer Inst Monogr. 2025 Mar 1; 2025 (68):49-55
    View PubMed
  13. Snavely AC, Gunn HJ, Lee JW, Pugh SL, Barlow WE, Culakova E, Arnold KB, Kittel CA, Smith S, Hanlon BM, Tan AD, Dockter T, Zahrieh D, Dressler EV. Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP). J Natl Cancer Inst Monogr. 2025 Mar 1; 2025 (68):65-72
    View PubMed
  14. Dressler EV, Pugh SL, Gunn HJ, Unger JM, Zahrieh DM, Snavely AC. Practical design considerations for cluster randomized controlled trials: lessons learned in community oncology research. J Natl Cancer Inst Monogr. 2025 Mar 1; 2025 (68):56-64
    View PubMed
  15. Bandos H, Torres-Saavedra PA, Culakova E, Gunn HJ, Lee MK, Duan F, Cecchini RS, Unger JM, Dueck AC, Steingrimsson JA. Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials. J Natl Cancer Inst Monogr. 2025 Mar 1; 2025 (68):14-21
    View PubMed
  16. Enserro DM, Gunn HJ, Elsaid MI, Duan F, Pugh SL. Challenges to and considerations of designing cancer prevention trials. J Natl Cancer Inst Monogr. 2025 Mar 1; 2025 (68):49-55
    View PubMed
  17. Ma J, Dragojevic S, Remmes NB, Mendelson NL, Kloeber JA, Ebner DK, Wu Z, Gunn H, Merrell K, Hallemeier CL, Haddock MG, Jethwa K, Lou Z, Mutter RW, Callaghan C. Linear Energy Transfer Optimized Proton Therapy for Rectal Cancer International Journal of Radiation Oncology, Biology, Physics. 2025.
  18. Ma J, Dragojevic S, Remmes NB, Mendelson NL, Kloeber JA, Ebner DK, Wu Z, Gunn H, Merrell K, Hallemeier CL, Haddock MG, Jethwa K, Lou Z, Mutter RW, Callaghan C. Linear Energy Transfer Optimized Proton Therapy for Rectal Cancer International Journal of Radiation Oncology, Biology, Physics. 2025.
  19. Vargas C, Corbin K, McGee L, Mutter R, Gunn H, Golafshar M, Dodoo C, Vallow L, Shumway D, Keole S, Park S, Halyard M, Cronin P, Pockaj B. Impact on outcomes of ultra hypofractionation or hypofractionation regimens and proton or Xrays therapy in a phase III randomized controlled trial MC1635. Front Oncol. 2025; 15:1557207 Epub 2025 Aug 06
    View PubMed
  20. Vargas C, Corbin K, McGee L, Mutter R, Gunn H, Golafshar M, Dodoo C, Vallow L, Shumway D, Keole S, Park S, Halyard M, Cronin P, Pockaj B. Impact on outcomes of ultra hypofractionation or hypofractionation regimens and proton or Xrays therapy in a phase III randomized controlled trial MC1635. Front Oncol. 2025; 15:1557207 Epub 2025 Aug 06
    View PubMed
  21. Chang GJ, Gunn HJ, Barber AK, Lowenstein LM, Dohan D, Broering J, Dockter T, Tan AD, Dueck A, Chow S, Neuman H, Finlayson E, OPTI-Surg Investigators. Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of a Presurgical Toolkit (OPTI-Surg)-Final Results of a Phase III Cluster Randomized Trial (Alliance A231601CD). Ann Surg. 2024 Oct 1; 280 (4):623-632 Epub 2024 July 29
    View PubMed
  22. Burlile JF, Shiraishi S, Gunn HJ, Bradt JL, Kroeplin HM, Lang KG, Cimmiyotti JK, Depauw N, Chang CY, Brom KM, Sonnicksen CL, Vu A, Jimenez RB, Corbin KS. Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparison. Acta Oncol. 2024 Oct 1; 63:755-762 Epub 2024 Oct 01
    View PubMed
  23. Gunn HJ, Zaniletti I, Breen WG, Leavitt T, Bogan A, Mahajan A, Brown PD, Yan E, Vora SA, Merrell KW, Ashman JB, Peterson JL, Leenstra JL, Wilson ZC, Laughlin BS, Laack NN, DeWees TA. Establishing the minimal clinically important difference of the Brief Fatigue Inventory for brain or CNS cancer patients undergoing radiotherapy. Neurooncol Pract. 2024 Oct; 11 (5):633-639 Epub 2024 Apr 27
    View PubMed
  24. Chang GJ, Gunn HJ, Barber AK, Lowenstein LM, Dohan D, Broering J, Dockter T, Tan AD, Dueck A, Chow S, Neuman H, Finlayson E, OPTI-Surg Investigators. Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of a Presurgical Toolkit (OPTI-Surg)-Final Results of a Phase III Cluster Randomized Trial (Alliance A231601CD). Ann Surg. 2024 Oct 1; 280 (4):623-632 Epub 2024 July 29
    View PubMed
  25. Gunn HJ, Zaniletti I, Breen WG, Leavitt T, Bogan A, Mahajan A, Brown PD, Yan E, Vora SA, Merrell KW, Ashman JB, Peterson JL, Leenstra JL, Wilson ZC, Laughlin BS, Laack NN, DeWees TA. Establishing the minimal clinically important difference of the Brief Fatigue Inventory for brain or CNS cancer patients undergoing radiotherapy. Neurooncol Pract. 2024 Oct; 11 (5):633-639 Epub 2024 Apr 27
    View PubMed
  26. Burlile JF, Shiraishi S, Gunn HJ, Bradt JL, Kroeplin HM, Lang KG, Cimmiyotti JK, Depauw N, Chang CY, Brom KM, Sonnicksen CL, Vu A, Jimenez RB, Corbin KS. Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparison. Acta Oncol. 2024 Oct 1; 63:755-762 Epub 2024 Oct 01
    View PubMed
  27. Conti RM, McCue S, Dockter T, Gunn HJ, Dusetzina SB, Bennett AV, Rapkin B, Gracia G, Jazowski S, Johnson M, Behrens R, Richardson P, Subbiah N, Chow S, Chang GJ, Neuman HB, Weiss ES. Self-Reported Financial Difficulties Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia Treated at U.S. Community Oncology Clinics (Alliance A231602CD). medRxiv 2024 Sep 18 Epub 2024 Sept 18
    View PubMed
  28. Conti RM, McCue S, Dockter T, Gunn HJ, Dusetzina SB, Bennett AV, Rapkin B, Gracia G, Jazowski S, Johnson M, Behrens R, Richardson P, Subbiah N, Chow S, Chang GJ, Neuman HB, Weiss ES. Self-Reported Financial Difficulties Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia Treated at U.S. Community Oncology Clinics (Alliance A231602CD). medRxiv 2024 Sep 18 Epub 2024 Sept 18
    View PubMed
  29. Sutton EA, Kamdem Talom BC, Ebner DK, Weiskittel TM, Breen WG, Kowalchuk RO, Gunn HJ, Day CN, Moore EJ, Holton SJ, Van Abel KM, Abdel-Halim CN, Routman DM, Waddle MR. Accuracy of a Cancer Registry Versus Clinical Care Team Chart Abstraction in Identifying Cancer Recurrence. Mayo Clin Proc Innov Qual Outcomes. 2024 Jun; 8(3):225-231. Epub 2024 Apr 21.
    View PubMed
  30. Sutton EA, Kamdem Talom BC, Ebner DK, Weiskittel TM, Breen WG, Kowalchuk RO, Gunn HJ, Day CN, Moore EJ, Holton SJ, Van Abel KM, Abdel-Halim CN, Routman DM, Waddle MR. Accuracy of a Cancer Registry Versus Clinical Care Team Chart Abstraction in Identifying Cancer Recurrence. Mayo Clin Proc Innov Qual Outcomes. 2024 Jun; 8(3):225-231. Epub 2024 Apr 21.
    View PubMed
  31. Burlile JF, Cameron J, Gunn H, Larson N, Boughey JC, Mrdutt MM, Couch F, Olson JE, Bradt JL, Sharifzadeh Y, Ruddy KJ, Shumway D, Loprinzi CL, Cathcart-Rake EJ. Defining musical toxicity after breast cancer treatment: a classification tree analysis. Journal of Clinical Oncology. 2024; 42(16 Suppl):12048.
  32. Burlile JF, Cameron J, Gunn H, Larson N, Boughey JC, Mrdutt MM, Couch F, Olson JE, Bradt JL, Sharifzadeh Y, Ruddy KJ, Shumway D, Loprinzi CL, Cathcart-Rake EJ. Defining musical toxicity after breast cancer treatment: a classification tree analysis. Journal of Clinical Oncology. 2024; 42(16 Suppl):12048.
  33. Zaniletti I, Gunn HJ, Hallemeier CL, Laughlin BS, Leavitt TR, Haddock MG, Merrell KW, Leenstra JL, May BC, Ashman JB, DeWees TA. Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy. Int J Radiat Oncol Biol Phys. 2024 Jan 1; 118 (1):137-141 Epub 2023 Aug 14
    View PubMed
  34. Zaniletti I, Gunn HJ, Hallemeier CL, Laughlin BS, Leavitt TR, Haddock MG, Merrell KW, Leenstra JL, May BC, Ashman JB, DeWees TA. Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy. Int J Radiat Oncol Biol Phys. 2024 Jan 1; 118 (1):137-141 Epub 2023 Aug 14
    View PubMed
  35. Ivory J, Wheeler SB, Drier S, Gunn H, Zahrieh D, Paskett E, Naughton M, Wills R, Swetel K, Chow S, Reeder-Hayes K. Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol. Trials. 2023 Oct 12; 24 (1):664
    View PubMed
  36. Ivory J, Wheeler SB, Drier S, Gunn H, Zahrieh D, Paskett E, Naughton M, Wills R, Swetel K, Chow S, Reeder-Hayes K. Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol. Trials. 2023 Oct 12; 24 (1):664
    View PubMed
  37. Le-Rademacher J, Gunn H, Yao X, Schaid DJ. Clinical Trials Overview: From Explanatory to Pragmatic Clinical Trials. Mayo Clin Proc. 2023 Aug; 98 (8):1241-1253
    View PubMed
  38. Le-Rademacher J, Gunn H, Yao X, Schaid DJ. Clinical Trials Overview: From Explanatory to Pragmatic Clinical Trials. Mayo Clin Proc. 2023 Aug; 98 (8):1241-1253
    View PubMed
  39. Gunn HJ, Hayati Rezvan P, Fernandez MI, Comulada WS. How to apply variable selection machine learning algorithms with multiply imputed data: A missing discussion. Psychol Methods. 2023 Apr; 28 (2):452-471 Epub 2022 Feb 03
    View PubMed
  40. Gunn HJ, Hayati Rezvan P, Fernandez MI, Comulada WS. How to apply variable selection machine learning algorithms with multiply imputed data: A missing discussion. Psychol Methods. 2023 Apr; 28 (2):452-471 Epub 2022 Feb 03
    View PubMed
  41. Devick KL, Gunn HJ, Price LL, Meinzen-Derr JK, Enders FT, Perkins SM, Schulte PJ. Collaborative biostatistics and epidemiology in academic medical centres: A survey to assess relationships with health researchers and ethical implications. Stat. 2022 Dec; 11 (1) Epub 2022 June 14
    View PubMed
  42. Devick KL, Gunn HJ, Price LL, Meinzen-Derr JK, Enders FT, Perkins SM, Schulte PJ. Collaborative biostatistics and epidemiology in academic medical centres: A survey to assess relationships with health researchers and ethical implications. Stat. 2022 Dec; 11 (1) Epub 2022 June 14
    View PubMed
  43. Zahrieh D, Hillman SL, Tan AD, Frank JL, Dockter T, Meyers BJ, Cherevko CL, Peil ES, McCue S, Kour O, Gunn HJ, Neuman HB, Chang GJ, Paskett ED, Mandrekar SJ, Dueck AC. Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience. Trials. 2022 Aug 09; 23(1):645.
    View PubMed
  44. Zahrieh D, Hillman SL, Tan AD, Frank JL, Dockter T, Meyers BJ, Cherevko CL, Peil ES, McCue S, Kour O, Gunn HJ, Neuman HB, Chang GJ, Paskett ED, Mandrekar SJ, Dueck AC. Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience. Trials. 2022 Aug 09; 23(1):645.
    View PubMed
  45. Tang W, Gunn HJ, Kwok S, Comulada WS, Arnold EM, Swendeman D, Fernandez MI, ATN masthead University of California, Los Angeles. Response Patterns to Weekly Short Message Service Health Surveys Among Diverse Youth at High Risk for Acquiring HIV. AIDS Behav. 2022 Jul; 26 (7):2229-2241 Epub 2022 Jan 11
    View PubMed
  46. Tang W, Gunn HJ, Kwok S, Comulada WS, Arnold EM, Swendeman D, Fernandez MI, ATN masthead University of California, Los Angeles. Response Patterns to Weekly Short Message Service Health Surveys Among Diverse Youth at High Risk for Acquiring HIV. AIDS Behav. 2022 Jul; 26 (7):2229-2241 Epub 2022 Jan 11
    View PubMed
  47. Comulada WS, Goldbeck C, Almirol E, Gunn HJ, Ocasio MA, Fernandez MI, Arnold EM, Romero-Espinoza A, Urauchi S, Ramos W, Rotheram-Borus MJ, Klausner JD, Swendeman D, Adolescent Medicine Trials Network (ATN) CARES Team. Using Machine Learning to Predict Young People's Internet Health and Social Service Information Seeking. Prev Sci. 2021 Nov; 22 (8):1173-1184 Epub 2021 May 11
    View PubMed
  48. Comulada WS, Goldbeck C, Almirol E, Gunn HJ, Ocasio MA, Fernandez MI, Arnold EM, Romero-Espinoza A, Urauchi S, Ramos W, Rotheram-Borus MJ, Klausner JD, Swendeman D, Adolescent Medicine Trials Network (ATN) CARES Team. Using Machine Learning to Predict Young People's Internet Health and Social Service Information Seeking. Prev Sci. 2021 Nov; 22 (8):1173-1184 Epub 2021 May 11
    View PubMed
  49. Gunn HJ, Grimm KJ, Edwards MC. Evaluation of six effect size measures of measurement non-invariance for continuous outcomes Structural Equation Modeling: A Multidisciplinary Journal. 2020; 27(4):503-514. Epub 2019 Nov 18.
  50. Gunn HJ, Grimm KJ, Edwards MC. Evaluation of six effect size measures of measurement non-invariance for continuous outcomes Structural Equation Modeling: A Multidisciplinary Journal. 2020; 27(4):503-514. Epub 2019 Nov 18.
  51. Pina AA, Gonzales NA, Mazza GL, Gunn HJ, Holly LE, Stoll RD, Parker J, Chiapa A, Wynne H, Tein JY. Streamlined Prevention and Early Intervention for Pediatric Anxiety Disorders: A Randomized Controlled Trial. Prev Sci. 2020 May; 21 (4):487-497
    View PubMed
  52. Pina AA, Gonzales NA, Mazza GL, Gunn HJ, Holly LE, Stoll RD, Parker J, Chiapa A, Wynne H, Tein JY. Streamlined Prevention and Early Intervention for Pediatric Anxiety Disorders: A Randomized Controlled Trial. Prev Sci. 2020 May; 21 (4):487-497
    View PubMed
  53. Sandler I, Wolchik S, Mazza G, Gunn H, Tein J-Y, Berkel C, Jones S, Porter M. Randomized effectiveness trial of the New Beginnings Program for divorced families with children and adolescents. J Clin Child Adolesc Psychol. 2019.
  54. Sandler I, Wolchik S, Mazza G, Gunn H, Tein J-Y, Berkel C, Jones S, Porter M. Randomized effectiveness trial of the New Beginnings Program for divorced families with children and adolescents. J Clin Child Adolesc Psychol. 2019.
  55. Sandler I, Gunn H, Mazza G, Tein JY, Wolchik S, Kim H, Ayers T, Porter M. Three perspectives on mental health problems of young adults and their parents at a 15-year follow-up of the family bereavement program. J Consult Clin Psychol. 2018 Oct; 86 (10):845-855
    View PubMed
  56. Sandler I, Gunn H, Mazza G, Tein JY, Wolchik S, Kim H, Ayers T, Porter M. Three perspectives on mental health problems of young adults and their parents at a 15-year follow-up of the family bereavement program. J Consult Clin Psychol. 2018 Oct; 86 (10):845-855
    View PubMed
  57. Mazza GL, Tein J-Y, Gunn HJ, Kim H, Stuart EA, Sandler IN, Wolchik S. Multigroup Propensity Score Approach to Evaluating an Effectiveness Trial of the New Beginnings Program. Evaluation & the Health Professions. 2018; 41(2):290-320. Epub 2018 Apr 10.
  58. Mazza GL, Tein J-Y, Gunn HJ, Kim H, Stuart EA, Sandler IN, Wolchik S. Multigroup Propensity Score Approach to Evaluating an Effectiveness Trial of the New Beginnings Program. Evaluation & the Health Professions. 2018; 41(2):290-320. Epub 2018 Apr 10.
  59. Sandler I, Gunn H, Mazza G, Tein JY, Wolchik S, Berkel C, Jones S, Porter M. Effects of a Program to Promote High Quality Parenting by Divorced and Separated Fathers. Prev Sci. 2018 May; 19 (4):538-548
    View PubMed
  60. Sandler I, Gunn H, Mazza G, Tein JY, Wolchik S, Berkel C, Jones S, Porter M. Effects of a Program to Promote High Quality Parenting by Divorced and Separated Fathers. Prev Sci. 2018 May; 19 (4):538-548
    View PubMed
  61. Gonzales NA, Knight GP, Gunn HJ, Tein J-Y, Tanaka R, White RMB. Intergenerational gaps in Mexican American values trajectories: Associations with parent-adolescent conflict and adolescent psychopathology Development and Psychopathology. 2018; 30(5):1611-1627.
  62. Gonzales NA, Knight GP, Gunn HJ, Tein J-Y, Tanaka R, White RMB. Intergenerational gaps in Mexican American values trajectories: Associations with parent-adolescent conflict and adolescent psychopathology Development and Psychopathology. 2018; 30(5):1611-1627.